GlassScriptPhysician profile
Kevin Ostrowski
NPI 1033352794
$64,104.83
in general payments reported to CMS, 2019-2025
25 companies · $372 in 2025
The $372 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,504 · 2020: $5,285 · 2021: $31K · 2022: $18K · 2023: $195 · 2024: $393 · 2025: $372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $961.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $961.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $45,074.37 | 2019-2025 | Titan |
| Boston Scientific Corporation | $17,780.67 | 2019-2025 | Lumenis Pulse 120h, Lithovue, Rezum Generator |
| 180 Medical, INC. | $391.17 | 2021-2025 | Gentlecath Glide, Speedicath, Gentlecath |
| Abbvie INC. | $113.43 | 2019 | |
| Progenics Pharmaceuticals, INC. | $90.06 | 2022-2025 | |
| Urogen Pharma, INC. | $74.89 | 2022-2024 | Jelmyto |
| Laborie Medical Technologies Corp. | $69.77 | 2023-2025 | |
| Tolmar Pharmaceuticals, INC. | $62.89 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $55.52 | 2024 | Orgovyx |
| Ferring Pharmaceuticals INC. | $46.14 | 2025 | Adstiladrin |
| Tolmar, INC. | $39.65 | 2023 | |
| Myovant Sciences INC. | $34.40 | 2021 | |
| Blue Earth Diagnostics | $33.69 | 2025 | Posluma |
| Endo USA, INC. | $26.50 | 2024 | Aveed |
| Astellas Pharma US INC | $26.27 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edap Technomed INC | $25.36 | 2023 | |
| Calyxo, INC. | $24.08 | 2024 | Cvac Aspiration System |
| Angiodynamics, INC. | $23.22 | 2025 | Nanoknife |
| Axonics, INC. | $20.89 | 2024 | Axonics |
| Ethicon INC. | $20.83 | 2022 | |
| Immunitybio, INC. | $19.07 | 2024 | |
| Endo Pharmaceuticals INC. | $17.01 | 2020 | |
| Emd Serono, INC. | $16.13 | 2019 | |
| Dentsply Ih Ab | $15.00 | 2022 | |
| Travere Therapeutics, INC. | $3.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Ostrowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.